Back
Vertex Pharmaceuticals 10K Form
Buy
63
VRTX
Vertex Pharmaceuticals
Last Price:
351.07
Seasonality Move:
0.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-11 | 10K | VRTX/Vertex Pharmaceuticals Annual |
| 2020-10-30 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2020-07-31 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2020-05-01 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2020-02-13 | 10K | VRTX/Vertex Pharmaceuticals Annual |
| 2019-10-31 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
Receive VRTX News And Ratings
See the #1 stock for the next 7 days that we like better than VRTX
VRTX Financial Statistics
Sales & Book Value
| Annual Sales: | $8.93B |
|---|---|
| Cash Flow: | $1.07B |
| Price / Cash Flow: | 23.55 |
| Annual Sales: | $60.01 |
| Price / Book: | 5.86 |
Profitability
| EPS (TTM): | 12.95000 |
|---|---|
| Net Income (TTM): | $3.36B |
| Gross Margin: | $7.85B |
| Return on Equity: | 24.46% |
| Return on Assets: | 18.74% |
Vertex Pharmaceuticals Earnings Forecast
Key Vertex Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 32 years for VRTX is 87.90%.
- The Selling, General & Administrative Expenses for VRTX have been equal to 10.58% of Gross Profit Margin.
- The Research & Development expenses have been 28.44% of Revenue.
- The Interest Expense is 1.65% of Operating Income.
- The Net Earning history of VRTX is 37.20% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 13 years.
Vertex Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | VRTX |
| CUSIP: | 92532F |
| Website: | vrtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.14 |
| Quick Ratio: | 3.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.39 |
|---|---|
| Forward P/E Ratio: | 21.76 |
VRTX Technical Analysis vs Fundamental Analysis
Buy
63
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $351.10. The Score for VRTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.